BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15973459)

  • 1. Multiple sclerosis genetics: leaving no stone unturned.
    Oksenberg JR; Barcellos LF
    Genes Immun; 2005 Aug; 6(5):375-87. PubMed ID: 15973459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomics and new targets for multiple sclerosis.
    Baranzini SE; Oksenberg JR
    Pharmacogenomics; 2005 Mar; 6(2):151-61. PubMed ID: 15882133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the genetics of multiple sclerosis.
    Baranzini SE; Oksenberg JR; Hauser SL
    J Rehabil Res Dev; 2002; 39(2):201-9. PubMed ID: 12051464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of autoimmune neuroinflammation.
    Olsson T; Jagodic M; Piehl F; Wallström E
    Curr Opin Immunol; 2006 Dec; 18(6):643-9. PubMed ID: 16973343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiple sclerosis as a polygenic disease: an update].
    Favorova OO; Kulakova OG; Boĭko AN
    Genetika; 2010 Mar; 46(3):302-13. PubMed ID: 20391774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetics of complex autoimmune diseases: non-MHC susceptibility genes.
    Wandstrat A; Wakeland E
    Nat Immunol; 2001 Sep; 2(9):802-9. PubMed ID: 11526390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis.
    Oksenberg JR; Baranzini SE; Sawcer S; Hauser SL
    Nat Rev Genet; 2008 Jul; 9(7):516-26. PubMed ID: 18542080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complex genetic aetiology of multiple sclerosis.
    Oksenberg JR; Barcellos LF
    J Neurovirol; 2000 May; 6 Suppl 2():S10-4. PubMed ID: 10871777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping gene activity in complex disorders: Integration of expression and genomic scans for multiple sclerosis.
    Fernald GH; Yeh RF; Hauser SL; Oksenberg JR; Baranzini SE
    J Neuroimmunol; 2005 Oct; 167(1-2):157-69. PubMed ID: 16129498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic risk factors in multiple sclerosis and approaches to their identification.
    Rasmussen HB; Clausen J
    J Neurovirol; 2000 May; 6 Suppl 2():S23-7. PubMed ID: 10871780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetics of clinical outcome in multiple sclerosis.
    Ramagopalan SV; Deluca GC; Degenhardt A; Ebers GC
    J Neuroimmunol; 2008 Sep; 201-202():183-99. PubMed ID: 18632165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
    Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in genetic analysis of multiple sclerosis: genetic associations and therapeutic implications.
    Niino M; Fukazawa T; Kikuchi S; Sasaki H
    Expert Rev Neurother; 2007 Sep; 7(9):1175-88. PubMed ID: 17868016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A search for multiple sclerosis susceptibility genes ].
    Sudomoina MA; Favorova OO
    Mol Biol (Mosk); 2000; 34(4):654-70. PubMed ID: 11042857
    [No Abstract]   [Full Text] [Related]  

  • 15. The genetics of multiple sclerosis.
    Hillert J
    Results Probl Cell Differ; 2010; 51():1-19. PubMed ID: 19582414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility locus on chromosome 1q23-25 for a schizophrenia subtype resembling deficit schizophrenia identified by latent class analysis.
    Holliday EG; McLean DE; Nyholt DR; Mowry BJ
    Arch Gen Psychiatry; 2009 Oct; 66(10):1058-67. PubMed ID: 19805696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine mapping of the multiple sclerosis susceptibility locus on 5p14-p12.
    Riise Stensland HM; Saarela J; Bronnikov DO; Parkkonen M; Jokiaho AJ; Palotie A; Tienari PJ; Sumelahti ML; Elovaara I; Koivisto K; Pirttilä T; Reunanen M; Sobel E; Peltonen L
    J Neuroimmunol; 2005 Dec; 170(1-2):122-33. PubMed ID: 16169605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus.
    Perera D; Stankovich J; Butzkueven H; Taylor BV; Foote SJ; Kilpatrick TJ; Rubio JP
    J Neuroimmunol; 2009 Jun; 211(1-2):105-9. PubMed ID: 19375175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian inference of epistatic interactions in case-control studies.
    Zhang Y; Liu JS
    Nat Genet; 2007 Sep; 39(9):1167-73. PubMed ID: 17721534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis: genomic rewards.
    Oksenberg JR; Baranzini SE; Barcellos LF; Hauser SL
    J Neuroimmunol; 2001 Feb; 113(2):171-84. PubMed ID: 11164900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.